All In MedTech

FDA Clearance Tracker · P030035-S164

Anthem, Allure/RF, Allure Quadra/RF family of CRT-Ps

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 11, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 11, 2018

Approved

Time to decision

83 days

Received Jan 18, 2018. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P030035-S164
Device name
Anthem, Allure/RF, Allure Quadra/RF family of CRT-Ps
Applicant location
Sylmar, CA
Received
Jan 18, 2018
Decided
Apr 11, 2018
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P030035

Device type

Device class
Class III

Every decision under product code NKE

FDA's approval statement

As written in FDA's record.

Approval for cybersecurity updates and implementation of a Battery Performance Alert in the firmware of ICDs and CRT-Ds.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.